"We are not stopping everything because of the virus": DNB has biotech fund launch on the horizon
In fact, a biotech fund might be a timely addition given the pandemic crisis we are currently facing, DNB Asset Management's Head of Equities says to AMWatch.
Log in to read our articles
Welcome to AMWatch. A part of our content is exclusive and reserved for our users.